Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Janzon

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Lakartidningen|January 31, 2018
Sofia Sunnerud, Eva Nylander, Magnus Janzon, et al.
British Journal of Sports Medicine|June 21, 2018
From guidelines to the sidelines: implementation of cardiovascular preparticipation evaluation in sports clubs is laggingKristofer Hedman, Sofia Sunnerud, Anna Carlén, et al.
BMJ Open|September 5, 2013
Strategies TO reduce time delays in patients with AcuTe coronary heart disease treated with primary PCI--the STOP WATCH study: a multistage action research projectTim Tödt, Ingela Thylén, Joakim Alfredsson, et al.
Scandinavian Cardiovascular Journal : SCJ|March 22, 2014
Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and DenmarkMartin Henriksson, Elisabet Nikolic, Audun Ohna, et al.
European Heart Journal|June 22, 2012
Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO studyElisabet Nikolic, Magnus Janzon, Ole Hauch, et al.
European Heart Journal|June 27, 2012
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in SwedenThomas Davidson, Magnus Husberg, Magnus Janzon, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry studyMagnus Janzon, Martin Henriksson, Pål Hasvold, et al.
International Journal of Cardiology. Heart & Vasculature|April 21, 2020
Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients - A real life cohort study of two treatment strategiesJoakim Alfredsson, Kime Omar, József Csog, et al.
European Heart Journal|January 15, 2015
Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspectiveTomas Jernberg, Pål Hasvold, Martin Henriksson, et al.
Scandinavian Journal of Primary Health Care|December 2, 2014
Cost consequences of point-of-care troponin T testing in a Swedish primary health care settingStaffan Nilsson, Agneta Andersson, Magnus Janzon, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Lakartidningen|January 31, 2018
Sofia Sunnerud, Eva Nylander, Magnus Janzon, et al.
British Journal of Sports Medicine|June 21, 2018
From guidelines to the sidelines: implementation of cardiovascular preparticipation evaluation in sports clubs is laggingKristofer Hedman, Sofia Sunnerud, Anna Carlén, et al.
BMJ Open|September 5, 2013
Strategies TO reduce time delays in patients with AcuTe coronary heart disease treated with primary PCI--the STOP WATCH study: a multistage action research projectTim Tödt, Ingela Thylén, Joakim Alfredsson, et al.
Scandinavian Cardiovascular Journal : SCJ|March 22, 2014
Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and DenmarkMartin Henriksson, Elisabet Nikolic, Audun Ohna, et al.
European Heart Journal|June 22, 2012
Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO studyElisabet Nikolic, Magnus Janzon, Ole Hauch, et al.
European Heart Journal|June 27, 2012
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in SwedenThomas Davidson, Magnus Husberg, Magnus Janzon, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry studyMagnus Janzon, Martin Henriksson, Pål Hasvold, et al.
International Journal of Cardiology. Heart & Vasculature|April 21, 2020
Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients - A real life cohort study of two treatment strategiesJoakim Alfredsson, Kime Omar, József Csog, et al.
European Heart Journal|January 15, 2015
Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspectiveTomas Jernberg, Pål Hasvold, Martin Henriksson, et al.
Scandinavian Journal of Primary Health Care|December 2, 2014
Cost consequences of point-of-care troponin T testing in a Swedish primary health care settingStaffan Nilsson, Agneta Andersson, Magnus Janzon, et al.
Pageof 8